Cargando…
Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolites
Fumarate hydratase–deficient (FH-deficient) renal cell carcinoma (RCC) represents a particularly aggressive form of kidney cancer. FH-deficient RCC arises in the setting of germline, or solely somatic, mutations in the FH gene, a two-hit tumor suppressor gene. Early detection can be curative, but th...
Autores principales: | Bezwada, Divya, Brugarolas, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231985/ https://www.ncbi.nlm.nih.gov/pubmed/37259915 http://dx.doi.org/10.1172/JCI170195 |
Ejemplares similares
-
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas
por: Yoo, Angela, et al.
Publicado: (2022) -
Governing glutaminolysis by regulation of glutaminase succinylation
por: Ma, Qingxia, et al.
Publicado: (2021) -
Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma
por: Rini, Brian I, et al.
Publicado: (2023) -
Common Variable Immunodeficiency and Circulating T(FH)
por: Coraglia, Ana, et al.
Publicado: (2016) -
HIRA loss transforms FH-deficient cells
por: Valcarcel-Jimenez, Lorea, et al.
Publicado: (2022)